Tetsuya Imamura

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Botulinum Toxin

Editorial Comment

Top Venues

Lower urinary tract symptoms

Tissue engineering. Part A

Neurourology and urodynamics

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Matsumoto, Tetsuya Imamura, Ryo Kitahara, Yoshihiro Inoue, Tetsuichi Saito, Manabu Ueno, Tomonori Minagawa, Teruyuki Ogawa, Osamu Ishizuka
Bi-layered Adipose Mesenchymal Cell Sheets Improve Bladder Compliance in Spinal Cord-Injured Rats. Tissue engineering. Part A (2024)
Tetsuya Imamura, Teruyuki Ogawa, Tomonori Minagawa, Hironori Daimon, Takashi Nagai, Manabu Ueno, Tetsuichi Saito, Osamu Ishizuka
Transient receptor potential ankyrin 1 channels in the bladder mediate low temperature elicited bladder overactivity in rats. Neurourology and urodynamics (2023)
Hiroaki Hara, Tetsuya Imamura, Ataru Suzuki, Manabu Ueno, Tomonori Minagawa, Teruyuki Ogawa, Osamu Ishizuka
Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M 3 -muscarinic antagonist and a β 3 -adrenergic agonist. Lower urinary tract symptoms 15 (2) (2022)
Noriyuki Ogawa, Tetsuya Imamura, Tomonori Minagawa, Teruyuki Ogawa, Osamu Ishizuka
Autologous Bilayered Adipose-Derived Mesenchymal Cell-Gelatin Sheets Reconstruct Ureters in Rabbits. Tissue engineering. Part A 28 (19-20) (2022)
Hiroaki Hara, Tetsuya Imamura, Ataru Suzuki, Manabu Ueno, Tomonori Minagawa, Teruyuki Ogawa, Osamu Ishizuka
Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M 3 -muscarinic antagonist and a β 3 -adrenergic agonist. Lower urinary tract symptoms 15 (2) (2022)
Hiroaki Hara, Tetsuya Imamura, Ataru Suzuki, Manabu Ueno, Tomonori Minagawa, Teruyuki Ogawa, Osamu Ishizuka
Cold stress-induced bladder overactivity in type 2 diabetic mellitus rats is mitigated by the combination of a M 3 -muscarinic antagonist and a β 3 -adrenergic agonist. Lower urinary tract symptoms (2022)